CircFOXO3 protects against osteoarthritis by targeting its parental gene FOXO3 and activating PI3K/AKT-mediated

Chen Zhao1, Xiaodong Li1, Guantong Sun1

  • 1Department of Orthopedics, Shanghai Key Laboratory of Orthopedic Implant, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

Cell Death & Disease
|November 7, 2022
PubMed

Insights

Circular RNA FOXO3 (circFOXO3) plays a key role in osteoarthritis (OA) progression. Overexpressing circFOXO3 may alleviate chondrocyte apoptosis and promote extracellular matrix anabolism, offering a new OA therapy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by pain and functional impairment.
  • Circular RNAs (circRNAs) are increasingly recognized for their significant roles in OA pathogenesis.
  • circFOXO3 is a novel circRNA implicated in OA development.

Purpose of the Study:

  • To investigate the role of circFOXO3 in osteoarthritis progression.
  • To elucidate the molecular mechanisms underlying circFOXO3's function in OA.
  • To evaluate circFOXO3 as a potential therapeutic target for OA.

Main Methods:

  • Western blot (WB), immunofluorescence (IF), RNA immunoprecipitation, RT-qPCR, and fluorescence in situ hybridization (FISH) were used to assess circFOXO3 function and interactions.
  • Transmission electron microscopy (TEM) and immunohistochemistry (IHC) evaluated autophagic flux.
  • A mouse model of OA was utilized to confirm in vivo effects.

Main Results:

  • Decreased circFOXO3 expression in OA cartilage correlated with increased chondrocyte apoptosis and extracellular matrix (ECM) imbalance.
  • circFOXO3 targets its parental gene, FOXO3, and activates autophagy.
  • Overexpression of circFOXO3 in an OA mouse model alleviated disease progression.

Conclusions:

  • circFOXO3 is a critical regulator of OA pathogenesis.
  • circFOXO3 overexpression can mitigate chondrocyte apoptosis and promote ECM anabolism through FOXO3 activation and autophagy.
  • circFOXO3 represents a promising therapeutic strategy for osteoarthritis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K